Skip to main content

Vertex

Vertex, headquartered in the United States, is a publicly listed biotechnology company dedicated to discovering, developing and commercialising medicines for serious diseases. Using proprietary technology platforms, Vertex advances therapies in areas such as cystic fibrosis, sickle cell disease and beta-thalassaemia, and maintains research and commercial operations globally. The firm focuses on highly specialised markets to deliver impactful treatments for patients.

North America
Pharmaceuticals & Biotechnology
Public
Not Engaged
Visit Website
ACT Core
F Non-mature
Just Transition
0.0/100
Nature Benchmark
9.4/100
Social Benchmark
18.1/100
Gender Assessment
29.4/100
On this page

Subscribe to stay informed on our work

Keep up to date with all the latest from World Benchmarking Alliance

Join our newsletter